Chemistry That Moves Medicines Forward
From Development To Dependable Supply
Pharmaceutical development demands more than chemistry alone. It calls for the right processes, the right infrastructure, and the discipline to take every molecule from an early-stage idea to reliable commercial supply.
Hikal partners with global pharmaceutical companies across this journey, from early lead generation through commercial launch. Our capabilities span conventional synthesis, complex chiral chemistry, custom synthesis, contract research, API and intermediate
KEY PROOF POINTS
API development experience
Scale-up and manufacturing capability
Standards supported through advanced analytical capabilities
Our Pharmaceutical Strengths
Our API portfolio spans established human health molecules, supported by regulatory expertise, scale-up capabilities, and robust manufacturing systems.
Solutions Built Around The Molecule
Different molecules demand different approaches. Our pharmaceutical capabilities bring together established API expertise, custom synthesis, intermediates, and development support to meet requirements across the product lifecycle.
Our API capabilities support the development of high-quality, reliable products for a broad range of therapeutic needs, with a focus on process consistency and commercial readiness.
Our R&T capabilities support the development of new and emerging molecules through innovative process chemistry, including enzymatic and flow chemistry approaches, helping accelerate platform readiness.
We develop and manufacture key intermediates with strong process control and quality discipline, enabling smooth progression from research through scale-up and supply.
Our custom synthesis expertise supports complex molecule development and targeted manufacturing needs, with flexible execution aligned to client timelines and technical requirements.
Connecting Every Stage Of Development
A successful CDMO partnership needs continuity from the first route to the final batch. Our model brings research, process chemistry, scale-up, manufacturing, quality, and supply together, creating a connected path from development to commercialisation.
RouteScouting
ProcessDevelopment
KiloLab
TechTransfer
CommercialManufacturing
Quality andCompliance
GlobalSupply
A Portfolio Built On Deep Chemistry
Our API and intermediate capabilities combine chemistry expertise, regulatory knowledge, scale-up capacity, and robust manufacturing systems. With more than two decades of API development experience, we support global customers across established products and a growing development pipeline.
| Application | Product | API or Intermediate | Status |
|---|---|---|---|
| Anti-diabetic | Vildagliptin | API | Pipeline |
| Anti-diabetic | Sitagliptin phosphate monohydrate | API | Pipeline |
| Anti-diabetic | Sitagliptin hydrochloride | API | Pipeline |
| Anti-diabetic | Canagliflozin | API | Pipeline |
| Anti-diabetic | Dapagliflozin | API | Pipeline |
| Anti-diabetic | Empagliflozin | API | Pipeline |
| Anti-diabetic | Ertugliflozin | API | Pipeline |
| Anti-thrombotic | Rivaroxaban intermediate | Intermediate | Pipeline |
| Anti-thrombotic | Apixaban intermediate | Intermediate | Pipeline |
| Anti-hypertensive | Losartan | API | Pipeline |
| Anti-hypertensive | Valsartan | API | Pipeline |
| Anti-inflammation | Celecoxib | API | Pipeline |
| Anti-inflammation | Naproxen | API | Pipeline |
| Analgesic | Tramadol | API | Pipeline |
| Analgesic | Paracetamol | API | Pipeline |
Where Every Milestone Connects
Complex pharmaceutical programs involve more than milestones and manufacturing dates. They require coordination across development, scale-up, technology transfer, quality, and commercialisation.Our project management system is designed around delivery within the agreed scope, duration, budget, and quality parameters, with project and product managers trained in the PRINCE2® project management method.